Upstream Bio

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$7.22-$33.68
Market Cap
$570.8M
Shares Short
3M

Financials

See more
Revenue (12 Mos)
$2.8M
Revenue Growth (YoY)
9%
Gross Profit (12 Mos)
$2.8M
Diluted EPS
-$2.66

News

See more

Yahoo Finance • 17 days ago

Wix downgraded, TripAdvisor upgraded: Wall Street's top analyst calls

Yahoo Finance • 22 days ago

ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch

Yahoo Finance • last month

Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced Therapies Rises | DelveInsight

Yahoo Finance • last month

Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting

About

CEO
Dr. E. Rand Sutherland M.D., M.P.H.
CFO
Mr. Michael Paul Gray CPA, MBA
Address
890 Winter Street, Waltham, MA, United States, 02451
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
75